Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers

• Ling Leng,
• Mansheng Li,
• Wei Li,
• Danlei Mou,
• Guopeng Liu,
• Jie Ma,
• Shuyang Zhang,
• Hongjun Li,
• Ruiyuan Cao,
• Wu Zhong

Affiliations

Ling Leng

Stem cell and Regenerative Medicine Lab, Department of Medical Science Research Center, State Key Laboratory of Complex Severe and Rare Diseases, Translational Medicine Center, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

Mansheng Li

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics

Wei Li

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology

Danlei Mou

Department of Infectious Diseases, Beijing YouAn Hospital, Capital Medical University

Guopeng Liu

Department of Cardiovascular Surgery, Institute of Cardiac Surgery, PLA General Hospital

Jie Ma

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Life Omics

Shuyang Zhang

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

Hongjun Li

Department of Radiology, Beijing YouAn Hospital, Capital Medical University

Ruiyuan Cao

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology

Wu Zhong

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology